| Literature DB >> 24512078 |
Yan-Yan Cui, Chen Ling, Yuan-Yuan Zhang, Jian Huang, Jian-Zhong Liu1.
Abstract
BACKGROUND: Shikimic acid (SA) produced from the seeds of Chinese star anise (Illicium verum) is a key intermediate for the synthesis of neuraminidase inhibitors such as oseltamivir (Tamiflu®), an anti-influenza drug. However, plants cannot deliver a stable supply of SA. To avoid the resulting shortages and price fluctuations, a stable source of affordable SA is required. Although recent achievements in metabolic engineering of Escherichia coli strains have significantly increased SA productivity, commonly-used plasmid-based expression systems are prone to genetic instability and require constant selective pressure to ensure plasmid maintenance. Cofactors also play an important role in the biosynthesis of different fermentation products. In this study, we first constructed an E. coli SA production strain that carries no plasmid or antibiotic marker. We then investigated the effect of endogenous NADPH availability on SA production.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24512078 PMCID: PMC3923554 DOI: 10.1186/1475-2859-13-21
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Shikimic acid (SA) production by different strains
| BW25113 (Δ | 7.18 ± 0.95 | 0.15 ± 0.04 | 0.05 |
| BW25113 (Δ | 5.82 ± 0.04 | 0.23 ± 0.02 | 0.08 |
| BW25113 (Δ | 5.82 ± 0.57 | 0.26 ± 0.02 | 0.09 |
| SA110 | 5.91 ± 1.34 | 1.34 ± 0.15 | 0.21 |
| SA112 | 5.85 ± 0.46 | 1.70 ± 0.01 | 0.25 |
Figure 1Transcription levels of the and genes in the different strains.
Figure 2Shikimic acid production of CIChE strains at different triclosan concentrations.
Figure 3Gene copy number (line) and transcription level (column) of the gene in CIChE strains.
Figure 4Transcription levels of genes of interest in the CIChE strain SA110 and SA112 compared with those in BW25113 (ΔΔ).
Effect of over-expressing genes involved in NADPH synthesis on SA production in SA112
| SA112 (pMP5) | 4.79 ± 0.64 | 1.34 ± 0.09 | 0.22 | 1.93 ± 0.01 |
| SA112 (pMPsthA) | 5.78 ± 0.26 | 1.42 ± 0.07 | 0.24 | 1.61 ± 0.01 |
| SA112 (pMPpntAB) | 5.50 ± 0.11 | 1.89 ± 0.01 | 0.27 | 2.23 ± 0.01 |
| SA112 (pMPnadK) | 5.20 ± 0.34 | 1.92 ± 0.01 | 0.29 | 2.55 ± 0.01 |
| SA114 | 6.55 ± 0.30 | 2.99 ± 0.01 | 0.31 | 4.51 ± 0.01 |
| SA116 | 6.40 ± 0.51 | 3.12 ± 0.01 | 0.33 | 5.77 ± 0.01 |
Effect of overexpressing the gene on SA production in SA116
| SA116(pMP5) | 5.56 ± 0.76 | 1.83 ± 0.07 | 0.23 | 1.67 ± 0.02 |
| SA116(pMPsthA) | 6.73 ± 0.11 | 1.69 ± 0.11 | 0.20 | 0.74 ± 0.04 |
Figure 5Transcription levels of the (open bar) and (black bar) in the different strains.
Strains and plasmids used in this study
| Strain | ||
| Invitrogen | ||
| 28 | ||
| This study | ||
| This study | ||
| This study | ||
| SA110 | CIChE strain of the | This study |
| SA112 | SA110 with an additional chromosomal copy of the | This study |
| SA114 | SA112 with an additional chromosomal copy of the | This study |
| SA116 | SA112 with an additional chromosomal copy of the | This study |
| Plasmid | ||
| pHKKF3T5b | CIChE integration expression vector, | 16 |
| pHKKT5b | Integration expression plasmid, | 33,34 |
| pP21KT5b | Integration expression plasmid, | 33,34 |
| pAH69 | Helper plasmid expressing phage HK022 Int, Ampr | 31 |
| pAH121 | Helper plasmid expressing phage P21 Int, Ampr | 31 |
| pCP20 | pSC101 repliconts Flp(λR | 28 |
| pKD3 | 28 | |
| pSIM6 | pSC101 repliconts PL | 29 |
| p5TG | pSC101 repliconts, 5Ptac promoter, Spcr | 32 |
| pMP5 | P5TG derivative, pSC101 | This study |
| pBAD24 | pMB1 | 30 |
| pBAD-csrB-pps | pBAD24 derivative containing the | Lab storage |
| pBEB | pBAD24 derivative containing the | This study |
| pBEBG | pBAD24 derivative containing the | This study |
| pHKEBG | pHKKF3T5b derivative containing | This study |
| pHKEBGT | pHKKF3T5b derivative containing | This study |
| pMPsthA | pMP5 derivative containing | This study |
| pMPpntAB | pMP5 derivative containing | This study |
| pMPnadK | pMP5 derivative containing | This study |
| pP21KT5b-csrB-pps | pP21KT5b derivative containing | This study |
| pHKKT5b-tktA | pHKKT5b derivative containing | This study |
| pHKK5Tacb | Integration expression plasmid, | This study |
| pP21K5Tacb | Integration expression plasmid, | This study |
| pP21K5Tacb-pntAB | pHK5Tacb derivative containing | This study |
| pP21K5Tacb-nadk | pHK5Tacb derivative containing | This study |
Primers used in this study
| LP1 | 5’-ATGACACAACCTCTTTTTCTGATCGGGCCTCGGGGCTGTGGTAAAACAACAGCGATTGTGTAGGCTGGAG-3’, deletion of |
| LP2 | 5’-TCAACAATTGATCGTCTGTGCCAGGGCGCTGCGAATTTCAGAAATCACCTTAACGGCTGACATGGGAATTAG-3’, deletion of |
| P1 | 5’-GTTTCGTTGGCATCGTTCTT-3’, Diagnostic PCR for the deletion of |
| P2 | 5’-ATTCTCATGACACCGGCTTT-3’, Diagnostic PCR for the deletion of |
| KP1 | 5’-ATGGCAGAGAAACGCAATATCTTTCTGGTTGGGCCTATGGGTGCCGGAAAAGCGATTGTGTAGGCTGGAG-3’, deletion of |
| KP2 | 5’-TTAGTTGCTTTCCAGCATGTGAATAATCTGGTTTGCAACCACTTTAGCGCTTAACGGCTGACATGGGAATTAG-3’, deletion of |
| P3 | 5’-GCGAAGCGGGTTTATCATTA-3’, Diagnostic PCR for the deletion of |
| P4 | 5’-GTTCCCCGAGAGTAACGAC-3’, Diagnostic PCR for the deletion of |
| GP1 | 5 |
| GP2 | 5’-CGGCATGCTTACCCGCGACGCGCTTTTACT-3’, |
| G15P1 | 5’-CTCAATATGATCACCCCACAAT-3’, sited-specific mutagenesis of |
| G15P2 | 5’-AAACTCACCTGCCGCTGGCAGACCG-3’, sited-specific mutagenesis of |
| EP1 | 5’-GCGAATTCAGGAG |
| EP2 | 5’-CGGCGGCCGCTTA |
| BP1 | 5’-CGGCGGCCGCAGGAG |
| BP2 | 5’-GCCCATGGTTACGCTGATTGACAATCGG-3’, |
| TP1 | 5’-GCGCATGCAGGAG |
| TP2 | 5’-CGGAGCTCTTACAGCAGTTCTTTTGCTTTCG-3’, |
| PntF | 5’-CAGGGTACCTCATCAATAAAACCG-3’, |
| PntR | 5’-CGTCTGCAGTTACAGAGCTTTCAG-3’, |
| SthF | 5’-TTTTGGTACCCAGGTAAGCCCTACCATGC-3’, |
| SthR | 5’-GGGCTGCAGGGCCATTTCGATAAAGTTTT-3’, |
| NadF | 5’-GCGGGGTACCATGAATAATCATTTCAAGTG-3’, |
| NAdR | 5’-GCGGTCTAGATTAGAATAATTTTTTTGACCA-3’, |
| 5TacF | 5’-ACGCGTGTAAAACGACGGCCAGT-3’, |
| 5TacR | 5'-CCGCGCATGCGGATCCGAATTCATGCATCTAGTATTTCTCCTCTTTAATGGAT-3’, |
| CsrF | 5’-CGGAGCTCAGGAGGTAATAAATGAGTCAGACAACGAAGTGAACAT-3’, |
| PpsR | 5’-CGGGTACCTTATTTCTTCAGTTCAGCCAGG-3’, |
| QEF | 5’-GGATCGCCGGAATATCACCAC-3’, qPCR for the |
| QER | 5’-ACTACTGCCACTCCTTTCCCT-3’, qPCR for the |
| QBF | 5’-AAC GAA ACC CTG GCT CCT CTG-3’, qPCR for the |
| QBR | 5’-AAGCGCCACCAGCGTAGTATC-3’, qPCR for the |
| QGF | 5’-CGTTGCTGAAGTGAAAGAAGGG-3’, qPCR for the |
| QGR | 5’-ACGTCAGCACAAACATCCATC-3’, qPCR for the |
| QTF | 5’-TTTCGCCTGGCCTGCTTCTTT-3’, qPCR for the |
| QTR | 5’-CGACGCTGAAATTGCCCTGAC-3’, qPCR for the |
| QNF | 5’-TGGAATCAACCGTGGCAACCT-3’, qPCR for the |
| QNR | 5’-TGGAATCAACCGTGGCAACCT-3’, qPCR for the |
| QPF | 5’-AGCCGGAGTACGAGTTCAGCA-3’, qPCR for the |
| QPR | 5’-ATTGCGCTGGTATTCGGCTGG-3’, qPCR for the |
| QPPF | 5’-GACATCTTCTCGCTGACCAAC-3’, qPCR for the |
| QPPR | 5’-TTACCGGTGTGGCCATCTTTC-3’, qPCR for the |
| QCSF | 5’-CTGGATGAAGCGAAGAGGATG-3’ , qPCR for the |
| QCSR | 5’-ATTGCTTCCTGCTCACACCAC-3’, qPCR for the |
| QCF | 5’-TTGTCGGCGGTGGTGATGTC-3’, qPCR for the |
| QCR | 5’-ATGCGGTGAACTGTGGAATAAACG-3’, qPCR for the |
aRestriction enzyme sites are underlined.